Bitcoin is trading stubbornly below the $100,000 mark, putting the brakes on a blistering post-election rally.
Related Posts
Pharma is hopeful about Trump’s second term — here’s what to expect for drugmakers
Drugmakers hope to see efforts that focus more on cracking down on pharmacy benefit managers while promoting drug innovation and patient access to treatments.
Mortgage demand stalls as financial markets digest Trump presidency
While tiny, the week’s increase in total application volume marked the first rise in overall demand in seven weeks.
Democrats press Pfizer, J&J and others over low tax bills and lobbying as Senate debates Trump’s plan
The lawmakers accuse Pfizer, Merck, J&J, AbbVie and Amgen of paying little to nothing in federal taxes despite generating billions of dollars annually.